1-8-20 China-developed Sinovac’s vaccine reported 78% efficacy rate in Brazil’s trials. It is stepping closer to official approval in China and experts said it is a “good vaccine” in results, but further data needed.
Brazil to acquire 100 mln Sinovac’s vaccine